Burjeel reports 129% increase in Q2 net profit, revenue grows 18.7%
Revenue in H1'25 rose 12.2% to AED2,677 million, with total patient visits reaching 3.4 million, the healthcare provider said.
EBITDA rose 59.4% to AED306 million in Q2 2025, fueled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes AED72 million in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The EBITDA margin expanded 5.6 p.p. to 21.8%. In H1'25, EBITDA increased 14.2% to AED487 million, with a margin of 18.2%.
Net profit surged 128.9% to AED148 million ($40.29 million) in Q2' 2025, reflecting margin expansion, enhanced operating leverage, and asset optimization. In H1'25, net profit rose 10.6% to AED187 million.
Specialised Services, expansion
Burjeel Holdings accelerated its strategic execution in Q2 2025 with a series of high-impact initiatives that deepened specialisation and broadened patient access. The group expanded its advanced oncology network, integrating Dubai's Advanced Care Oncology Center and opening new Burjeel Cancer Institute (BCI) clinics in Al Ain, Sharjah, and Oman, reinforcing its position as a regional leader in complex cancer care. The UAE's first dedicated cancer pharmacy was also inaugurated, strengthening oncology support infrastructure.
In parallel, Burjeel launched a regional mental health platform through its joint venture Alkalma, opening four specialist mental health centers across the UAE and Saudi Arabia. This marked the first phase of a multi-year expansion strategy aimed at addressing rising demand for mental wellness services. In Saudi Arabia, the Group acquired a major physiotherapy facility in Riyadh under the PhysioTherabia platform, adding scale and unlocking turnaround potential through secured government contracts.
Investments in operational resilience and access continued with the AED170 million acquisition of the Medeor Hospital Dubai building, converting long-term lease obligations into ownership and enhancing cost structure flexibility.
The group also expanded its primary care footprint with a new medical center launched on Saadiyat Island, aligning with its growth strategy in high-yield urban catchments.
In medical innovation, Burjeel launched Docktour, a transformative healthcare logistics joint venture with AD Ports Group, aiming to redefine how medical services and infrastructure are delivered to underserved and remote communities. Several specialised centers were introduced, including the region's first Al Muderis Osseointegration Clinic for advanced limb reconstruction, a state-of-the-art Epilepsy Monitoring Unit, and expanded capabilities in rare diseases, hematology, and metabolic research. Additionally, the Group continued its digital transformation with AI-powered diagnostics and led groundbreaking research in microgravity, aiming to transform care for patients with diabetes in space and on Earth.
John Sunil, Chief Executive Officer of Burjeel Holdings, said: 'The second quarter delivered exceptionally strong results, with 19% revenue growth driven by a 12% increase in patient footfall and improved yield. EBITDA rose by 59%, accompanied by a margin uplift to 22%. This robust performance significantly strengthened the first-half outcome, underscoring Burjeel Holdings' resilience and long-term sustainable growth.
'These results reflect tangible progress in key operational areas such as physician manpower optimization, formulary management, and cost control, while our strategic focus on super-specialty care is beginning to yield measurable benefits, enhancing both revenue and profitability. We continue to invest in high-value services and next-generation care facilities to support long-term momentum.
'We also advanced key strategic priorities, reinforcing leadership in complex care across oncology, transplants, fertility, mental health, and diagnostics. Our oncology platform is now the UAE's largest private network, featuring new cancer clinics and cell and gene therapy capabilities. The Alkalma mental health platform is scaling regionally, alongside rehabilitation services through over 30 PhysioTherabia centers in Saudi Arabia. Additionally, we introduced the region's first Osseointegration Clinic for cutting-edge prosthetic care.
'In parallel with expanding our network of primary care and medical centers, we deepened partnerships with government and corporate stakeholders and accelerated digital integration through Oracle Health EMR and AI-powered tools. Building on this platform, we entered into pivotal partnerships in oncology, value-based care, diagnostics, and international healthcare innovation, establishing the Group as the healthcare partner of choice.
'Burjeel Holdings is uniquely positioned to capture significant opportunities across the region, supported by rising demand for complex care and a growing population. Our focus remains on converting recent investments into sustained expansion and margin improvement, while maintaining disciplined financial management to support long-term shareholder value. Net profit growth of 129% in the reporting quarter reinforces this trajectory and strengthens the foundation for consistent shareholder returns.'
Growth drivers
Oncology remained a core growth driver, with revenue rising 36.7% in Q2'25 and 38.1% in H1'25, underpinned by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded solid gains in H1'25, including urology (+18%), emergency medicine (+17%), cardiology (+16%), and gastroenterology (+13%).
Inpatient footfall rose 17.7% in Q2'25, reflecting strong demand across key specialties and a ramp-up in elective surgeries post-Ramadan. The group performed 22,930 surgeries, up 18.7%, with momentum concentrated at Burjeel Medical City, Burjeel Specialty Hospital Sharjah, Lifecare Hospital Musaffah and Burjeel Royal Hospital Al Ain. Bed occupancy improved to 69%, up from 65% a year ago, and averaged 69% in H1'25. Inpatient volumes rose 14.6% over the first half.
Outpatient footfall grew 12.0% in Q2'25, accelerating from 5.2% in Q1, driven by primary care and physiotherapy centers, along with robust demand in oncology, pediatrics, ophthalmology, and family medicine. Utilization improved to 68%, up from 65% in Q1'25, enabled by optimized hiring and scaling of clinical teams. Leading facilities included Burjeel Medical City, Lifecare Hospital Baniyas, and Burjeel Day Surgery Center Barari. In H1'25, outpatient volumes increased 8.6%.
Syndigate.info).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
4 minutes ago
- Zawya
Dubai's Amanat signs SPA sell real estate assets for $123mln
Dubai DFM-listed Amanat Holding has entered into an SPA (sale and purchase agreement) for the sale of the real estate assets of North London Collegiate School to a buyer for 453 million dirhams ($123.3 million). The sale and transfer of the property is expected to be completed in Q3 2025. Click here to download infographic Amanat invests in and operates education and healthcare assets in the UAE, including International Medical Center, Sukoon, Abu Dhabi University Holding Company and Middlesex University Dubai. (Writing by Brinda Darasha; editing by Mily Chakrabarty)
Gulf Business
17 minutes ago
- Gulf Business
FiLLi Cafe partners with COFE Cloud to drive global expansion
Image: Supplied UAE-based tea brand The agreement centres on a customised mobile app built on COFE Cloud's digital solutions platform, which is aimed at helping coffee and beverage brands scale efficiently while improving customer experience. The brand, which operates in the UAE, US, UK, Oman, Qatar, Mauritius, Nepal, India and Pakistan, is looking to accelerate its international growth with COFE Cloud's data-driven tools, operational streamlining and customer engagement capabilities. 'We are proud to support FiLLi, one of the UAE's most iconic café brands, on their next chapter of growth,' said Ali Al Ebrahim, founder and CEO of COFE. 'By bringing our advanced digital infrastructure to their expansion strategy, we aim to redefine what's possible for regional brands scaling globally.' FiLLi to get a fully customised app COFE Cloud's system will give the retail brand a fully customised app to reflect local preferences across different markets and improve operational efficiency, revenue growth and brand loyalty. 'Partnering with COFE Cloud marks a significant milestone in our digital journey,' said Rafih FiLLi, founder and CEO of FiLLi Cafe. 'This collaboration enables us to seamlessly scale our operations while staying true to our brand promise—delivering world-famous Zafran Chai and Global Street Food with excellence, speed, and personalisation.' Founded in 2004 as a single café in the UAE, FiLLi has grown into a global brand known for its modern take on street food fusion and signature chai. COFE, founded in 2018, operates in Kuwait, Saudi Arabia, UAE and Egypt, with further expansion planned.
Khaleej Times
34 minutes ago
- Khaleej Times
Meeting every child where they are: ABLE UK offers personalised, multidisciplinary paediatric therapy services in Dubai
ABLE UK is founded on one core belief: each child is unique, and their care plan should reflect that. The centre works with children of all ages facing developmental delays, including autism spectrum disorder, ADHD, learning difficulties, and other behavioural or neurological challenges. Whether a child is dealing with speech delays, coordination issues, sensory processing differences, or more complex diagnoses, the team delivers personalised, evidence-based interventions tailored to their strengths, needs, and environment. All services are offered in one convenient location at Building 33 – 1st and 2nd Floor, Dubai Healthcare City, ensuring integrated care and easier access for families. The centre's comprehensive range of therapies includes: Applied Behaviour Analysis (ABA): A research-backed approach for children with autism or behavioural needs, enhancing communication, learning, and social skills through structured reinforcement. Occupational Therapy (OT): Helping children build essential life and learning skills for independence. Myofunctional Therapy (MFT): Addressing breathing and oral function issues that affect facial growth and development. Speech and Language Therapy (SLT): Supporting expressive, receptive, and social communication in children facing language delays or articulation issues. Oral Placement Therapy (OPT) & Feeding Therapy (FT): Improving oral motor skills and feeding for children with sensory or motor-based challenges. Physiotherapy (PT): Supporting mobility, strength, and coordination for children with neurological or physical needs, including expertise in working with preterm infants. Psychological Assessments: Led by in-house clinical psychologist Mr. Joey Sura, the diagnostic services identify developmental, learning, or attention challenges. The team also supports schools by providing assessments for children who need accommodations. STEPS Transition Programme: Designed to prepare children for mainstream or special education settings, STEPS run according to the school calendar and builds both academic and functional school-readiness skills. This includes pre-literacy, numeracy, classroom behaviour, social interaction, and daily routines, offering a smooth and confident transition into formal education. Training & Mentorship: Intensive training programmes are provided for the in-house team, parents, and the broader professional community. ABLE UK also mentors newly graduated professionals and regularly invites global experts to the UAE for specialist workshops. In-house Training Centre Facility: This space is designed to host professional training programmes, workshops, and events. It supports ongoing development for the team, parents, and the wider community through expert-led sessions, mentorship, and hands-on learning opportunities. Expanding into DMCC To meet growing demand, ABLE UK has opened a new branch in Jumeirah Lakes Towers (DMCC), offering families in central and southern Dubai easier access to the full range of multidisciplinary services. The new branch maintains the same high standard of care, aligned with the mission to make expert intervention accessible and timely. Beyond therapy: Advocating for inclusion On July 25, 2025, ABLE UK was recognised by the Hidden Disabilities Sunflower program, becoming one of the first paediatric centres in the Middle East to receive this honour. This global initiative promotes understanding and visibility for people with non-visible disabilities in schools, airports, and other public spaces. Aman Sura, director of ABLE UK, shared: 'Joining the Sunflower initiative reflects our commitment to inclusion. We want every child-whether their challenges are visible or not to feel supported and seen.' Gursaran Sura, CEO and co-founder, added: 'When we started in 2015 with a small team, we knew the UAE needed a child-first, integrated therapy model. Today, we've helped hundreds of children build not just skills, but confidence. Many are now thriving in mainstream schools and daily life.' ABLE UK is also proud of its culturally responsive care. With many children in the UAE growing up bilingual or multilingual, therapists adapt assessments to reflect linguistic and cultural diversity, ensuring results are accurate and meaningful. Real-life results, lasting change What sets ABLE UK apart is its commitment to ongoing growth. The team actively refines tools and interventions based on real-life conditions - such as attention span, environment, and motivation so that gains made in the clinic transfer to the home, school, and beyond. Parents consistently describe their experience at ABLE UK as transformative. One mother shared: 'We had visited several clinics before, but only at ABLE UK did we feel truly understood. They didn't just assess our son - they built a plan that worked and supported us throughout.' Because services are integrated, families experience fewer delays and more consistent, collaborative support. Psychologists, therapists, and educators work in sync to ensure each child receives the right help at the right time. A message to families: Don't wait If there's one message ABLE UK hopes families take to heart, it's this: early action matters. Intervening during the early developmental years can make a profound difference in a child's path. Waiting often leads to increased emotional, social, and academic difficulties later on. As one of the lead psychologists puts it: 'A diagnosis isn't a label - it's a roadmap. It gives families clarity, direction, and most importantly, options.' With over 350 children supported weekly across more than 17,000 sq ft of world-class therapy space, ABLE UK is more than a clinic. It's a centre of possibility, inclusion, and lasting impact. To learn more, visit:
